This major role of MMP-9 in GCA was confirmed using a human artery-SCID-mouse model in which wall inflammation was induced in human vessels engrafted to immunodeficient mice that were immunoreconstituted with PBMC from patients with GCA. This evidence concerns the gene MMP9 and temporal arteritis.